Utilization of radiomics to predict long-term outcome of magnetic resonance–guided focused ultrasound ablation therapy in adenomyosis

article OA: closed CC0 ⤵ 5 in-corpus citations
AI-generated summary by claude@2026-07, 2026-07-14

A T2-weighted MRI radiomics model incorporating clinical parameters predicted MR-guided focused ultrasound treatment response in adenomyosis patients, achieving an AUC of 0.81 in the testing cohort.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-14 · read from full text

This retrospective single-institution study developed a T2-weighted MRI radiomics prediction model, using 69 adenomyosis patients treated with MR-guided focused ultrasound (MRgFUS), and split them into training (n=48) and testing (n=21) cohorts. From 1,118 T2 radiomics features extracted pre-treatment, the authors used normalization and Pearson correlation reduction followed by feature selection with analysis of variance and logistic regression (fivefold cross-validation) to build models comparing clinical features alone, radiomics alone, and a combined radiomics-clinical model. The radiomics model selected four features and showed predictive capability for poor response, while the combined radiomics-clinical model achieved good discrimination with an AUC of 0.81 in the testing cohort, supported by decision curve analysis; the paper notes nearly one third of patients remained symptomatic at 6 months after MRgFUS. This paper is centrally about endometriosis—specifically, it focuses on adenomyosis outcomes after MRgFUS using T2 radiomics prediction.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

ObjectiveTo develop and evaluate a T2 MR-based radiomics prediction model incorporating radiomics features and clinical parameters to predict the response to magnetic resonance-guided focused ultrasound surgery (MRgFUS) in patients with adenomyosis.Materials and methodsSixty-nine patients (mean age, 38.6 years; age range, 26-50 years) with adenomyosis treated by MRgFUS were reviewed and allocated to training (n = 48) and testing cohorts (n = 21). One thousand one hundred eighteen radiomics features were extracted from T2-weighted imaging before MRgFUS. The radiomics features' dimension was reduced by Pearson correlation coefficient after normalization. Analysis of variance and logistical regression were used for feature selection by fivefold cross-validation in the training cohort, and the machine learning model was constructed for comparing the clinical model, radiomics model, and radiomics-clinical model which combined survived radiomics features and clinical parameters. The discrimination result of the model was obtained by bootstrap; receiver operating characteristic curve, area under the curve (AUC), and decision curve analyses were performed to illustrate the model performance in both the training and testing cohorts.ResultsGood response was achieved in 47 patients (68.1%) and failed in 22 patients (38.9%). The radiomics model comprised four selected features and demonstrated a degree of prediction capability of patients' poor response to MRgFUS treatment. The radiomics-clinical model showed good discrimination, with an AUC of 0.81 (95% confidence interval, 0.592-0.975) in the testing cohort. The decision curve analysis also showed favorable performance of the radiomics-clinical model.ConclusionsA prediction model composed of T2WI-based radiomics features and clinical parameters could be applied to guide the radiologist to evaluate MRgFUS for patients with adenomyosis who will achieve good response.Key points• Magnetic resonance imaging-guided focused ultrasound surgery represents an alternative treatment for adenomyosis, but nearly one third of patients remain symptomatic 6 months after MRgFUS. • Combining four radiomics features of T2-weighted MRI with eight clinical features further improves prediction of poor responders to MR-guided focused ultrasound treatment of uterine adenomyosis (AUC = 0.81 in the testing cohort). • The radiomics model based on T2-weighted imaging combined with clinical parameters can help predict which patients are likely to have a good response to MRgFUS for adenomyosis.
Full text 10,950 characters · extracted from oa-doi-fallback · 5 sections · click to expand

Abstract

Objective To develop and evaluate a T2 MR–based radiomics prediction model incorporating radiomics features and clinical parameters to predict the response to magnetic resonance–guided focused ultrasound surgery (MRgFUS) in patients with adenomyosis.

Materials and methods

Sixty-nine patients (mean age, 38.6 years; age range, 26–50 years) with adenomyosis treated by MRgFUS were reviewed and allocated to training (n = 48) and testing cohorts (n = 21). One thousand one hundred eighteen radiomics features were extracted from T2-weighted imaging before MRgFUS. The radiomics features’ dimension was reduced by Pearson correlation coefficient after normalization. Analysis of variance and logistical regression were used for feature selection by fivefold cross-validation in the training cohort, and the machine learning model was constructed for comparing the clinical model, radiomics model, and radiomics-clinical model which combined survived radiomics features and clinical parameters. The discrimination result of the model was obtained by bootstrap; receiver operating characteristic curve, area under the curve (AUC), and decision curve analyses were performed to illustrate the model performance in both the training and testing cohorts.

Results

Good response was achieved in 47 patients (68.1%) and failed in 22 patients (38.9%). The radiomics model comprised four selected features and demonstrated a degree of prediction capability of patients’ poor response to MRgFUS treatment. The radiomics-clinical model showed good discrimination, with an AUC of 0.81 (95% confidence interval, 0.592–0.975) in the testing cohort. The decision curve analysis also showed favorable performance of the radiomics-clinical model.

Conclusions

A prediction model composed of T2WI-based radiomics features and clinical parameters could be applied to guide the radiologist to evaluate MRgFUS for patients with adenomyosis who will achieve good response. Key Points • Magnetic resonance imaging–guided focused ultrasound surgery represents an alternative treatment for adenomyosis, but nearly one third of patients remain symptomatic 6 months after MRgFUS. • Combining four radiomics features of T2-weighted MRI with eight clinical features further improves prediction of poor responders to MR-guided focused ultrasound treatment of uterine adenomyosis (AUC = 0.81 in the testing cohort). • The radiomics model based on T2-weighted imaging combined with clinical parameters can help predict which patients are likely to have a good response to MRgFUS for adenomyosis. Similar content being viewed by others Abbreviations - L 3mm3DGLCMinverse variance : - T2 log sigma 3–0-mm 3D GLCM inverse variance - W HLHFOmedian : - T2 wavelet HLH first-order median - W HLLFOminimum : - T2 wavelet HLL first-order minimum - W LLHNGTDMstrength : - T2 wavelet LLH NGTDM strength - AUC: - Area under the ROC curve - DCA: - Decision curve analysis - GR: - Good responders - HIFU: - High-intensity focused ultrasound - MRgFUS: - Magnetic resonance–guided focused ultrasound surgery - NRS: - Numerical rating scales (to assess pain severity) - NSAIDs: - Non-steroidal anti-inflammatory drugs - PR: - Poor responders - ROC: - Receiver operating characteristic curve - SSS: - Symptom severity score - UFS-QOL: - Uterine fibroid symptom and quality of life

References

Garavaglia E, Audrey S, Annalisa I et al (2015) Adenomyosis and its impact on women fertility. Iran J Reprod Med 13:327–336 Vercellini P, Vigano P, Somigliana E, Daguati R, Abbiati A, Fedele L (2006) Adenomyosis: epidemiological factors. Best Pract Res Clin Obstet Gynaecol 20:465–477 Azziz R (1989) Adenomyosis: current perspectives. Obstet Gynecol Clin North Am 16:221–235 Struble J, Reid S, Bedaiwy MA (2016) Adenomyosis: a clinical review of a challenging gynecologic condition. J Minim Invasive Gynecol 23:164–185 Nishida M (1991) Relationship between the onset of dysmenorrhea and histologic findings in adenomyosis. Am J Obstet Gynecol 165:229–231 Krentel H, Cezar C, Becker S et al (2017) From clinical symptoms to MR imaging: diagnostic steps in adenomyosis. Biomed Res Int 2017:1514029 Younes G, Tulandi T (2017) Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis. Fertil Steril 108:483–490.e483 Parazzini F, Mais V, Cipriani S, Busacca M, Venturini P (2009) Determinants of adenomyosis in women who underwent hysterectomy for benign gynecological conditions: results from a prospective multicentric study in Italy. Eur J Obstet Gynecol Reprod Biol 143:103–106 Cline HE, Hynynen K, Watkins RD et al (1995) Focused US system for MR imaging-guided tumor ablation. Radiology 194:731–737 Fan TY, Zhang L, Chen W et al (2012) Feasibility of MRI-guided high intensity focused ultrasound treatment for adenomyosis. Eur J Radiol 81:3624–3630 Fukunishi H, Funaki K, Sawada K, Yamaguchi K, Maeda T, Kaji Y (2008) Early results of magnetic resonance-guided focused ultrasound surgery of adenomyosis: analysis of 20 cases. J Minim Invasive Gynecol 15:571–579 Zhou M, Chen JY, Tang LD, Chen WZ, Wang ZB (2011) Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center. Fertil Steril 95:900–905 Lee JS, Hong GY, Park BJ, Kim TE (2015) Ultrasound-guided high-intensity focused ultrasound treatment for uterine fibroid & adenomyosis: a single center experience from the Republic of Korea. Ultrason Sonochem 27:682–687 Jayaram R, Subbarayan K, Mithraprabhu S, Govindarajan M (2016) Heavy menstrual bleeding and dysmenorrhea are improved by magnetic resonance guided focused ultrasound surgery (MRgFUS) of adenomyosis. Fertil Res Pract 2:8 Guo Y, Duan H, Cheng J, Zhang Y (2017) Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis: a clinical study. BJOG 124(Suppl 3):7–11 Chen J, Chen W, Zhang L et al (2015) Safety of ultrasound-guided ultrasound ablation for uterine fibroids and adenomyosis: a review of 9988 cases. Ultrason Sonochem 27:671–676 Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577 Lambin P, Rios-Velazquez E, Leijenaar R et al (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441–446 Aerts HJ, Velazquez ER, Leijenaar RT et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006 Blagus R, Lusa L (2013) SMOTE for high-dimensional class-imbalanced data. BMC Bioinformatics 14:106–106 Spies JB, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves SM (2002) The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol 99:290–300 Williamson A, Hoggart B (2005) Pain: a review of three commonly used pain rating scales. J Clin Nurs 14:798–804 Yushkevich PA, Piven J, Hazlett HC et al (2006) User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 31:1116–1128 Gareth James DW, Hastie T, Tibshirani R (2013) The lasso. In: Berra Y (ed) An introduction to statistical learning with applications in R. Springer, Berlin, p 225 Bazot M, Cortez A, Darai E et al (2001) Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology. Hum Reprod 16:2427–2433 Stamatopoulos CP, Mikos T, Grimbizis GF et al (2012) Value of magnetic resonance imaging in diagnosis of adenomyosis and myomas of the uterus. J Minim Invasive Gynecol 19:620–626 Reinhold C, McCarthy S, Bret PM et al (1996) Diffuse adenomyosis: comparison of endovaginal US and MR imaging with histopathologic correlation. Radiology 199:151–158 Takeuchi M, Matsuzaki K (2011) Adenomyosis: usual and unusual imaging manifestations, pitfalls, and problem-solving MR imaging techniques. Radiographics 31:99–115 Levgur M, Abadi MA, Tucker A (2000) Adenomyosis: symptoms, histology, and pregnancy terminations. Obstet Gynecol 95:688–691 Taran FA, Weaver AL, Coddington CC, Stewart EA (2010) Understanding adenomyosis: a case control study. Fertil Steril 94:1223–1228 Shrestha A (2012) Risk factors for adenomyosis. J Nepal Health Res Counc 10:229–233 Mattonen SA, Tetar S, Palma DA, Louie AV, Senan S, Ward AD (2015) Imaging texture analysis for automated prediction of lung cancer recurrence after stereotactic radiotherapy. J Med Imaging (Bellingham) 2:041010 Mattonen SA, Palma DA, Haasbeek CJ, Senan S, Ward AD (2014) Early prediction of tumor recurrence based on CT texture changes after stereotactic ablative radiotherapy (SABR) for lung cancer. Med Phys 41:033502 Liu Z, Zhang XY, Shi YJ et al (2017) Radiomics analysis for evaluation of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Clin Cancer Res 23:7253–7262 Acknowledgments This research is financially supported by the National Natural Science Foundation of China (81871400, 81671740, 81771816, and 61731009), the Shanghai Academic/Technology Research Leader Program (17XD1424200), and the Excellent Academic Leaders of Shanghai of the Shanghai Municipal Commission of Health (2017BR038). Funding This study has received funding from the National Natural Science Foundation of China, Shanghai Academic/Technology Research Leader Program, and Excellent Academic Leaders of Shanghai of the Shanghai Municipal Commission of Health. Author information Authors and Affiliations Corresponding author Ethics declarations Guarantor The scientific guarantor of this publication is Han Wang. Conflict of interest The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. Statistics and biometry One of the authors has significant statistical expertise. Informed consent Written informed consent was waived by the Institutional Review Board. Ethical approval Institutional Review Board approval was obtained. Study subjects or cohorts overlap Some study subjects or cohorts have been previously reported in European Radiology. Methodology • retrospective • diagnostic or prognostic study/observational/performed at one institution Additional information Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Electronic supplementary material ESM 1 (download DOCX ) (DOCX 137 kb) Rights and permissions About this article Cite this article Li, Z., Zhang, J., Song, Y. et al. Utilization of radiomics to predict long-term outcome of magnetic resonance–guided focused ultrasound ablation therapy in adenomyosis. Eur Radiol 31, 392–402 (2021). https://doi.org/10.1007/s00330-020-07076-1 Received: Revised: Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s00330-020-07076-1

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

MeSH descriptors

Adenomyosis Adenomyosis Adenomyosis Adult Area Under Curve Female Humans Magnetic Resonance Imaging Magnetic Resonance Spectroscopy Middle Aged Retrospective Studies

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (34)

Cited by (5)

Source provenance

europepmc
last seen: 2026-07-28T06:14:09.330459+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:21:47.975235+00:00
License: CC0 · commercial use OK